Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124846673 | 12484667 | 3 | F | 20160513 | 20160617 | 20160621 | 20160714 | EXP | US-FRI-1000085498 | FOREST | 51.89 | YR | M | Y | 0.00000 | 20160714 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124846673 | 12484667 | 1 | PS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 20 MG, QD | 5940 | MG | 21323 | 20 | MG | TABLET | QD | ||||
124846673 | 12484667 | 2 | SS | BLINDED INVESTIGATIONAL MEDICINAL PRODUCT (IMP) NON-PARTNER | INVESTIGATIONAL PRODUCT | 1 | Oral | UNK | 0 | TABLET | |||||||||
124846673 | 12484667 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
124846673 | 12484667 | 4 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | 2 PUFFS , PRN | 0 | ||||||||||
124846673 | 12484667 | 5 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, QD | 0 | 25 | MG | QD | |||||||
124846673 | 12484667 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
124846673 | 12484667 | 7 | C | LORATADINE. | LORATADINE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
124846673 | 12484667 | 8 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 50 ?G, QD (2 SPRAYS) | 0 | 50 | UG | QD | |||||||
124846673 | 12484667 | 9 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0.4 MG, QD | 0 | .4 | MG | QD | |||||||
124846673 | 12484667 | 10 | C | RANITIDINE. | RANITIDINE | 1 | Oral | 300 MG, QD | 0 | 300 | MG | QD | |||||||
124846673 | 12484667 | 11 | C | FLOVENT | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 2 PUFFS, BID | 0 | BID | |||||||||
124846673 | 12484667 | 12 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124846673 | 12484667 | 1 | Major depression |
124846673 | 12484667 | 2 | Major depression |
124846673 | 12484667 | 3 | Hypertension |
124846673 | 12484667 | 4 | Asthma |
124846673 | 12484667 | 5 | Hypertension |
124846673 | 12484667 | 6 | Blood cholesterol increased |
124846673 | 12484667 | 7 | Hypersensitivity |
124846673 | 12484667 | 8 | Hypersensitivity |
124846673 | 12484667 | 9 | Prostatomegaly |
124846673 | 12484667 | 10 | Gastrooesophageal reflux disease |
124846673 | 12484667 | 11 | Asthma |
124846673 | 12484667 | 12 | Gastrooesophageal reflux disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124846673 | 12484667 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124846673 | 12484667 | Abdominal pain | |
124846673 | 12484667 | Dizziness | |
124846673 | 12484667 | Mitral valve incompetence |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124846673 | 12484667 | 1 | 20150722 | 20160517 | 0 | |
124846673 | 12484667 | 2 | 20151118 | 20160517 | 0 | |
124846673 | 12484667 | 3 | 2008 | 0 | ||
124846673 | 12484667 | 4 | 1988 | 0 | ||
124846673 | 12484667 | 5 | 2013 | 0 | ||
124846673 | 12484667 | 6 | 2010 | 0 | ||
124846673 | 12484667 | 7 | 2010 | 0 | ||
124846673 | 12484667 | 8 | 201406 | 0 | ||
124846673 | 12484667 | 9 | 20150728 | 0 | ||
124846673 | 12484667 | 10 | 20151027 | 0 | ||
124846673 | 12484667 | 11 | 20151101 | 0 | ||
124846673 | 12484667 | 12 | 20160128 | 0 |